Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 293

1.
2.

Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.

Chen J, Chen Y, Luo Y, Gui D, Huang J, He D.

Eur J Pharmacol. 2014 Aug 5;736:86-94. doi: 10.1016/j.ejphar.2014.04.037. Epub 2014 May 6.

PMID:
24809932
3.

Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes.

Sayyed SG, Hägele H, Kulkarni OP, Endlich K, Segerer S, Eulberg D, Klussmann S, Anders HJ.

Diabetologia. 2009 Nov;52(11):2445-54. doi: 10.1007/s00125-009-1493-6. Epub 2009 Aug 26.

PMID:
19707743
4.

Altering expression of alpha3beta1 integrin on podocytes of human and rats with diabetes.

Chen HC, Chen CA, Guh JY, Chang JM, Shin SJ, Lai YH.

Life Sci. 2000 Sep 29;67(19):2345-53.

PMID:
11065181
5.

Glomerular barrier dysfunction in glomerulosclerosis- resistant Milan rats with experimental diabetes: the role of renal haemodynamics.

Pugliese G, Ricci C, Iacobini C, Menini S, Fioretto P, Ferrandi M, Giardino LA, Armelloni S, Mattinzoli D, Rastaldi MP, Pugliese F.

J Pathol. 2007 Oct;213(2):210-8. Erratum in: J Pathol. 2007 Oct;213(2):218.

PMID:
17768702
6.

[Effects of DL-alpha-lipoic acid on the experimentally induced diabetic cataract in rats].

Sun L, Zhang JS.

Zhonghua Yan Ke Za Zhi. 2004 Mar;40(3):193-6. Chinese.

PMID:
15307993
8.

Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes.

Lee EY, Chung CH, Kim JH, Joung HJ, Hong SY.

Nephrol Dial Transplant. 2006 Jun;21(6):1496-503. Epub 2006 Feb 16.

PMID:
16484238
9.

Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.

Yamaguchi Y, Iwano M, Suzuki D, Nakatani K, Kimura K, Harada K, Kubo A, Akai Y, Toyoda M, Kanauchi M, Neilson EG, Saito Y.

Am J Kidney Dis. 2009 Oct;54(4):653-64. doi: 10.1053/j.ajkd.2009.05.009. Epub 2009 Jul 17.

PMID:
19615802
10.

Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.

Isermann B, Vinnikov IA, Madhusudhan T, Herzog S, Kashif M, Blautzik J, Corat MA, Zeier M, Blessing E, Oh J, Gerlitz B, Berg DT, Grinnell BW, Chavakis T, Esmon CT, Weiler H, Bierhaus A, Nawroth PP.

Nat Med. 2007 Nov;13(11):1349-58. Epub 2007 Nov 4.

PMID:
17982464
11.

Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes.

Gross ML, Ritz E, Schoof A, Adamczak M, Koch A, Tulp O, Parkman A, El-Shakmak A, Szabo A, Amann K.

Lab Invest. 2004 Apr;84(4):452-64.

12.

Pentoxifylline diminishes the oxidative damage to renal tissue induced by streptozotocin in the rat.

Dávila-Esqueda ME, Martínez-Morales F.

Exp Diabesity Res. 2004 Oct-Dec;5(4):245-51.

13.

Alpha-lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats.

Gouty S, Regalia J, Cai F, Helke CJ.

Auton Neurosci. 2003 Oct 31;108(1-2):32-44.

PMID:
14614962
14.

Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.

Wang S, Li Y, Zhao J, Zhang J, Huang Y.

Biol Blood Marrow Transplant. 2013 Apr;19(4):538-46. doi: 10.1016/j.bbmt.2013.01.001. Epub 2013 Jan 4.

15.

Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy.

Lin J, Bierhaus A, Bugert P, Dietrich N, Feng Y, Vom Hagen F, Nawroth P, Brownlee M, Hammes HP.

Diabetologia. 2006 May;49(5):1089-96. Epub 2006 Mar 7.

PMID:
16520919
16.

Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.

Blanco S, Vaquero M, Gómez-Guerrero C, López D, Egido J, Romero R.

Am J Hypertens. 2005 Apr;18(4 Pt 1):557-65.

PMID:
15831368
17.

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.

Gross ML, El-Shakmak A, Szábó A, Koch A, Kuhlmann A, Münter K, Ritz E, Amann K.

Diabetologia. 2003 Jun;46(6):856-68. Epub 2003 Jun 11.

PMID:
12802493
18.

Effect of lipoic acid on cyclophosphamide-induced diabetes and insulitis in non-obese diabetic mice.

Faust A, Burkart V, Ulrich H, Weischer CH, Kolb H.

Int J Immunopharmacol. 1994 Jan;16(1):61-6.

PMID:
8150556
19.

Vasopeptidase inhibition attenuates proteinuria and podocyte injury in Zucker diabetic fatty rats.

Fredersdorf S, Weil J, Ulucan C, Birner C, Büttner R, Schubert T, Böger CA, Debl K, Muders F, Riegger GA, Luchner A.

Naunyn Schmiedebergs Arch Pharmacol. 2007 Apr;375(2):95-103. Epub 2007 Mar 1.

PMID:
17333128
20.

Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.

Novelli M, D'Aleo V, Lupi R, Paolini M, Soleti A, Marchetti P, Masiello P.

Pancreas. 2007 Nov;35(4):e10-7.

PMID:
18090226

Supplemental Content

Support Center